Latest profit margin for Innovation Pharmaceuticals: 44183.33% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
As of the most recent data (September 2023), IPIX shows a profit margin of 44183.33%. That compares with -36894.44% in the prior-year period — up 219.8% year over year. That is above the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, IPIX's profit margin is now 44183.33% (was -36894.44%) — a 219.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Innovation Pharmaceuticals is outperforming or lagging.
The Healthcare sector average profit margin is about 17.63%. Innovation Pharmaceuticals is at 44183.33%, which is higher that average. That is roughly 250535.8% above the sector mean. Use the comparison chart on this page to see how IPIX stacks up against individual peers as well.
That compares with -36894.44% in the prior-year period — up 219.8% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Innovation Pharmaceuticals with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Innovation Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 44183.33%) with ownership activity and broader fundamentals.